A Texas researcher received a $219,000 NIH grant to study the potential of a treatment for radiation-induced pulmonary ...

Living with pulmonary fibrosis, columnist Ann Reynoso writes, means no more independent, spontaneous days with enough energy ...

Over the coming months, the Pulmonary Fibrosis Foundation's 2025 PFF Walk will aim to raise more than $1 million for the ...

Clinical trials are an important part of IPF research, says columnist Sam Kirton, but we need people willing to participate in them.

That’s according to top-line data from the Phase 2b CORAL trial (NCT05964335), which is evaluating three doses of the experimental oral therapy against a placebo, taken twice a day, in 165 adults.

For most of my life, I welcomed those muggy days of summer. But with my diagnosis of idiopathic pulmonary fibrosis (IPF) in January 2017, I didn’t realize that was about to change and I’d have to ...

FIBRONEER-IPF (NCT05321069) enrolled 1,177 IPF patients, while FIBRONEER-ILD (NCT05321082) enrolled 1,176 adults with progressive forms of pulmonary fibrosis other than IPF. Because the studies met ...

Let-7, an established tumor suppressor microRNA that controls gene activity, plays a key role in lung tissue repair and the development of pulmonary fibrosis (PF), which is marked by scarring of the ...

The first few days after my idiopathic pulmonary fibrosis (IPF) diagnosis in January 2017 were a blur. I had what now? What is that? There’s no cure? That can’t be good. My wife, Susan, was with me as ...